BH, GTIV, ESRX, PT, AMAT, GENZ Are Seasonally Ripe To Go Up In the Next Five Weeks
December 2, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of BIGLARI HOLDINGS INC. (NYSE:BH), GENTIVA HEALTH SERVICES (NASDAQ:GTIV), EXPRESS SCRIPTS INC (NASDAQ:ESRX), PORTUGAL TELECOM SGPS-SP ADR (NYSE:PT), APPLIED MATERIALS INC (NASDAQ:AMAT), GENZYME CORP (NASDAQ:GENZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Up:
Symbol Company Expected Return Odds By The Following Date BH BIGLARI HOLDINGS INC. 9.340 % 73.08% (19 of 26) Thursday, December 30th 2010 GTIV GENTIVA HEALTH SERVICES 9.330 % 90.00% (9 of 10) Friday, January 14th 2011 ESRX EXPRESS SCRIPTS INC 9.310 % 83.33% (15 of 18) Monday, January 3rd 2011 PT PORTUGAL TELECOM SGPS-SP ADR 9.300 % 86.67% (13 of 15) Friday, January 7th 2011 AMAT APPLIED MATERIALS INC 9.220 % 77.78% (21 of 27) Friday, January 14th 2011 GENZ GENZYME CORP 9.110 % 83.33% (20 of 24) Friday, January 14th 2011
BIGLARI HOLDINGS INC. (NYSE:BH) - BIGLARI HOLDINGS INC.
GENTIVA HEALTH SERVICES (NASDAQ:GTIV) - Gentiva Health Services, Inc. provides home health services in the United States. The company offers skilled nursing and therapy services, paraprofessional nursing services, and homemaker services primarily to adult and elderly patients through licensed and Medicare-certified agencies. It also provides its services through specialty programs comprising Gentiva Orthopedics, which offers individualized home orthopedic rehabilitation services; Gentiva Safe Strides that provides therapies for patients with balance issues; and Gentiva Cardiopulmonary, which helps patients and their physicians manage heart and lung health in a home-based environment. In addition, the company provides services through Gentiva Neurorehabilitation that offers therapies for patients with neurological injury; Gentiva Senior Health, which addresses the needs of patients with age-related diseases; and Rehab Without Walls unit that provides neurorehabilitation therapies for patients with traumatic brain injury, cerebrovascular accident injury, and acquired brain injury. Further, it offers hospice services and consulting services. The company was founded in 1999 and is headquartered in Atlanta, Georgia.
EXPRESS SCRIPTS INC (NASDAQ:ESRX) - Express Scripts, Inc. provides a range of pharmacy benefit management (PBM) services in North America. The companys PBM services include retail network pharmacy management and retail drug card programs; home delivery pharmacy services; specialty pharmacy services; patient care contact centers; benefit plan design and consultation; drug formulary management; compliance and therapy management programs; information reporting and analysis programs; rebate programs, electronic claims processing, and drug utilization review; consumer health and drug information; bio-pharma services, including reimbursement and customized logistics solutions; medication therapy and safety through pharmacogenomics; and assistance programs for low-income patients. It also engages in the distribution of pharmaceuticals and medical supplies to providers and clinics; fertility pharmaceuticals requiring special handling or packaging; and sample units to physicians, as well as the verification of practitioner licensure, healthcare account administration, and implementation of consumer-directed healthcare solutions. It serves HMOs, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, and retina specialists. Express Scripts was founded in 1986 and is headquartered in St. Louis, Missouri.
PORTUGAL TELECOM SGPS-SP ADR (NYSE:PT) - Portugal Telecom, SGPS, S.A. provides telecommunications services in Portugal, Brazil, and Africa. The company offers wireline services, which include fixed line telephone services for residential and nonresidential customers; leased lines; unbundled local loop access and wholesale line rental; interconnection; Internet access through dial-up and broadband asymmetric digital subscriber line (ADSL); data and business solutions; portal; and e-commerce services. It also provides mobile telecommunications services comprising voice, data, and Internet-related services. In addition, the company offers Internet protocol television and direct-to-home satellite pay-TV services, as well as sells telecommunications equipment. As of December 31, 2009, Portugal Telecom had approximately 4.6 million telephone and ADSL access lines in service. It has strategic alliances with Telefonica S.A.; Banco Espirito Santo Group; and Caixa Geral de Depositos. The company was formerly known as Portugal Telecom, SA and changed its name to Portugal Telecom, SGPS, S.A. in December 2000. Portugal Telecom, SGPS, S.A. was founded in 1994 and is based in Lisboa, Portugal.
APPLIED MATERIALS INC (NASDAQ:AMAT) - Applied Materials, Inc. provides nanomanufacturing technology solutions for the semiconductor, flat panel display, solar, and related industries worldwide. Its Silicon segment provides a range of manufacturing equipment used to fabricate semiconductor chips or integrated circuits. It offers systems that perform primary processes used in chip fabrication, including atomic layer deposition, chemical vapor deposition, physical vapor deposition, etch, rapid thermal processing, chemical mechanical planarization, and wafer metrology and inspection, as well as systems that etch, measure, and inspect circuit patterns on masks used in the photolithography process. The companys Applied Global Services segment offers products and services designed to improve the performance and productivity, and reduce the environmental impact of the fab operations of semiconductor, LCD, and solar photovoltaics manufacturers. Its Display segment provides equipment to fabricate thin film transistor LCDs for televisions, computer displays, and other consumer-oriented electronic applications. The companys Energy and Environmental Solutions segment offers manufacturing solutions for the generation and conservation of energy. It also provides manufacturing solutions for wafer-based crystalline silicon, and glass-based thin film applications to enable customers to increase the conversion efficiency and yields of solar PV devices. In addition, this segment offers roll-to-roll vacuum Web coating systems for deposition of a range of films on flexible substrates for functional, aesthetic, or optical properties, as well as large-area deposition equipment for the production of low-emissivity and solar control architectural glass. The company serves manufacturers of semiconductor wafers and chips, flat panel liquid crystal displays, solar photovoltaic cells and modules, and other electronic devices. Applied Materials, Inc. was founded in 1967 and is headquartered in Santa Clara, California.
GENZYME CORP (NASDAQ:GENZ) - Genzyme Corporation operates as a biotechnology company worldwide. It focuses on rare genetic disease disorders, renal diseases, orthopaedics, cancers, transplant and immune diseases, and diagnostic and predictive testing areas. The companys Genetic Diseases segment manufactures and distributes Cerezyme for the treatment of Gaucher disease; Fabrazyme for the treatment of Fabry disease; Myozyme for the treatment of Pompe disease; Aldurazyme for the treatment of Mucopolysaccharidosis I; and Elaprase for the treatment of Mucopolysaccharidosis II. Its Cardiometabolic and Renal segment offers Renagel and Renvela for the control of serum phosphorus in patients with chronic kidney disease on dialysis; Hectorol for the treatment of secondary hyperparathyroidism; and Thyrogen, an adjunctive diagnostic agent used in the follow-up of patients with well-differentiated thyroid cancer. The companys Biosurgery segment provides Synvisc, a biomaterial-based product that is used to treat the pain associated with osteoarthritis of the knee; and Sepra family of products to prevent adhesions following various surgical procedures in the abdomen and pelvis. Its Hematologic Oncology segment develops products for the treatment of cancer, including Campath and Fludara for the treatment of leukemia and lymphoma; Clolar for the treatment of acute leukemia; Leukine for the reduction of the incidence of severe and life-threatening infections in older adult patients with AML following chemotherapy and certain other uses; and Mozobil for the mobilization of hematopoietic stem cells. The company has strategic alliances with Bayer; Osiris Therapeutics, Inc.; PTC Therapeutics, Inc.; and Isis Pharmaceuticals, Inc. It serves physicians, hospitals, treatment centers, other providers of medication to patients, retail pharmacies, and government agencies through distributors. The company was founded in 1981 and is based in Cambridge, Massachusetts.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641